Difficulty: Medium
Average Score: 78%
Practice
Which of the following antienzymes is a fibrinolysis inhibitor?
Correct answer
C
Rationale
In the context of pharmacology, understanding antienzymes plays a crucial role in managing various health conditions. In this question, the correct answer is C) Aminocaproic acid, which is a fibrinolysis inhibitor. Aminocaproic acid works by preventing the breakdown of blood clots by inhibiting plasmin, the enzyme responsible for fibrinolysis.
Option A) Clavulanic acid is not a fibrinolysis inhibitor; it is a beta-lactamase inhibitor used in combination with antibiotics to enhance their efficacy against bacteria.
Option B) Sulbactam is also a beta-lactamase inhibitor used in combination with antibiotics to combat bacterial resistance.
Option D) Disulfiram is an alcohol-sensitizing agent used in the management of alcohol dependence, not as a fibrinolysis inhibitor.
Educationally, knowing the specific actions of different antienzymes is essential for healthcare professionals, especially pharmacists and nurses, to make informed decisions about drug therapy. Understanding the mechanisms of action of drugs like aminocaproic acid can help in selecting the most appropriate treatment options for patients with conditions where fibrinolysis inhibition is necessary, such as in cases of severe bleeding or certain clotting disorders.
Option A) Clavulanic acid is not a fibrinolysis inhibitor; it is a beta-lactamase inhibitor used in combination with antibiotics to enhance their efficacy against bacteria.
Option B) Sulbactam is also a beta-lactamase inhibitor used in combination with antibiotics to combat bacterial resistance.
Option D) Disulfiram is an alcohol-sensitizing agent used in the management of alcohol dependence, not as a fibrinolysis inhibitor.
Educationally, knowing the specific actions of different antienzymes is essential for healthcare professionals, especially pharmacists and nurses, to make informed decisions about drug therapy. Understanding the mechanisms of action of drugs like aminocaproic acid can help in selecting the most appropriate treatment options for patients with conditions where fibrinolysis inhibition is necessary, such as in cases of severe bleeding or certain clotting disorders.